Compare CBK & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBK | AQST |
|---|---|---|
| Founded | 1975 | 2004 |
| Country | United States | United States |
| Employees | 298 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 483.7M | 529.4M |
| IPO Year | 2025 | 2007 |
| Metric | CBK | AQST |
|---|---|---|
| Price | $34.76 | $5.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 31.7K | ★ 3.7M |
| Earning Date | 04-27-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | ★ 16.14 | N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | $11.67 | $10.08 |
| Revenue Next Year | $8.05 | $49.60 |
| P/E Ratio | $49.01 | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $23.24 | $2.94 |
| 52 Week High | $35.78 | $7.55 |
| Indicator | CBK | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 65.72 |
| Support Level | $33.33 | $3.70 |
| Resistance Level | $34.46 | $5.41 |
| Average True Range (ATR) | 0.69 | 0.25 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 45.39 | 83.47 |
Commercial Bancgroup Inc is a bank holding company. Through its subsidiary, it operates as a full-service community banking institution offering traditional consumer and commercial products and services to businesses and individuals in select markets in Kentucky, North Carolina, and Tennessee. In Tennessee, its service areas include the metropolitan statistical areas of Nashville Davidson, Murfreesboro, Franklin, Knoxville, and the Tri Cities region of Kingsport, Bristol, and Johnson City, as well as Claiborne County, Cocke County, Union County, Hamblen County, and their surrounding areas.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.